Product

Product Search
Search for the product you’re interested in.
Recommended searches.
Search by Index
Search results for 'Prescription Drugs'
Total 77
Top Recommended
  • Improvement of dizziness caused by chronic cerebral circulation disorder following cerebral infarction
    Cardiovascular
    Ketas Cap. 10mg
  • 1) Management of edema associated with heart failure (i.e. congestive heart failure), cirrhosis of the liver (i.e. ascites), or renal disease; acute pulmonary edema 2) Management of essential or renal hypertension
    Cardiovascular
    Lasix Inj.
  • 1) Management of edema associated with heart failure (i.e. congestive heart failure), cirrhosis of the liver (i.e. ascites), or renal disease; peripheral vascular edema 2) Management of essential or renal hypertension
    Cardiovascular
    Lasix Tab.
  • Hyperlipidemia: hypercholesterolemia (type IIa), combined type of hypercholesterolemia and hypertriglyceridemia (type IIb, type III), hypertriglyceridemia (type IV)
    Metabolism / Cardiovascular
    Lipidil NT tablet
  • Hyperlipidemia: hypercholesterolemia (type IIa), combined type of hypercholesterolemia and hypertriglyceridemia (type IIb, type III), hypertriglyceridemia (type IV)
    Metabolism / Cardiovascular
    LIPIDIL SUPRA TAB.
  • Primary hypercholesterolemia: As an adjuvant to diet to reduce elevated total-cholesterol, LDL-cholesterol, apolipoprotein-B, triglycerides and non-HDL-cholesterol, and to increase HDL-cholesterol in patients with primary hypercholesterolemia (heterozygous familial and nonfamilial) or mixed dyslipidemia
    Cardiovascular
    Megarozet Tab. 10/5mg, 10/10mg, 10/20mg
  • Active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135. Menactra is approved for use in individuals 9 months through 55 years of age
    Vaccine
    Menactra Inj.
  • Combination with lenalidomide in adult patients with relapsed or refractory diffuse large B-cell lymphoma(DLBCL) who are not eligible for autologous stem cell transplant(ASCT) and failed one or more prior therapies, followed by this drug monotherapy.
    Oncology
    Minjuvi Inj.
  • Mircera is an erythropoiesis-stimulating agent (ESA) indicated for the treatment of anemia associated with chronic kidney disease (CKD in adult patients on dialysis and patients not on dialysis
    Kidney
    MIRCERA® injection
맨위로